Magic mushroom drug tested to fight depression without the 'Trip'
NCT ID NCT07210112
Summary
This study is testing a new approach for people with depression that hasn't improved with standard treatments. Researchers want to see if psilocybin, a compound from 'magic mushrooms,' can relieve depression even when its psychedelic effects are blocked by another drug called trazodone. They will compare different combinations of these drugs in 112 participants to understand how the treatment works and if it's safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GHU Paris Psychiatrie and Neurosciences
Paris, 75014, France
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.